Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Apr-24 4:32 PM View:  | Nivalis Therapeutics, Inc. (ALPN) | 25-Apr-24 | Sale | 19 | $64.57 | $1,226.83 | (< 1%) 2.83M to 2.83M | |
| 29-Apr-24 4:32 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 25-Apr-24 | Exercise (in-the money or at-the-money) | 1,200,000 | $0.00 | $1,200.00 | 74% 1.63M to 2.83M | |
| 28-Mar-24 4:30 PM View: | Newamsterdam Pharma Co N.V. (NAMS) | 26-Mar-24 | Market Purchase | 8,429 | $21.50 | $181,224.00 | < 1% 6.8M to 6.81M | (3%) |
| 13-Dec-23 5:30 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Dec-23 | Exercise (in-the money or at-the-money) | 145,251 | $12.74 | $1,850,500.00 | 10% 1.48M to 1.63M | |
| 30-May-23 7:03 PM View: | Phathom Pharmaceuticals, Inc. (PHAT) | 25-May-23 | Grant | 9,000 | -- | -- | < 1% 5.84M to 5.85M | |
| 11-Dec-20 4:05 PM View: | Frazier Lifesciences Acquis... (FLAC) | 11-Dec-20 | Grant | 501,000 | $10.00 | $5,010,000.00 | 100% 0 to 501.0K | |
| 11-Dec-20 4:05 PM View: | Frazier Lifesciences Acquis... (FLAC) | 11-Dec-20 | Purchase | 1,000,000 | $10.00 | $10,000,000.00 | 200% 501.0K to 1.5M | |
| 18-Nov-20 5:15 PM View: | Anaptysbio, Inc (ANAB) | 16-Nov-20 | Acquisition (other) | 48,958 | -- | -- | 2% 2.35M to 2.4M | |
| 18-Nov-20 5:15 PM View: | Anaptysbio, Inc (ANAB) | 16-Nov-20 | Disposition (other) | 1,416,750 | -- | -- | (59%) 2.4M to 980.51K | |
| 02-Apr-20 4:32 PM View: | Aptinyx Inc. (APTX) | 31-Mar-20 | Grant | 4,976 | $2.16 | $10,748.20 | < 1% 3.19M to 3.2M | 69% |
| 22-Jan-19 5:09 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Jan-19 | Market Purchase Duplicate | 372,439 | $5.37 | $2,000,000.00 | 17% 2.2M to 2.57M | 198% |
| 02-Oct-18 9:42 PM View: | Entasis Therapeutics Holdin... (ETTX) | 28-Sep-18 | Conversion Duplicate | 910,092 | -- | -- | 1423% 63.97K to 974.07K | |
| 02-Oct-18 9:42 PM View: | Entasis Therapeutics Holdin... (ETTX) | 28-Sep-18 | Purchase Duplicate | 375,887 | $15.00 | $5,638,300.00 | 39% 974.06K to 1.35M | |
| 26-Jun-18 4:54 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion Duplicate | 3,040,080 | -- | -- | 100% 0 to 3.04M | |
| 26-Jun-18 4:54 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Purchase Duplicate | 150,000 | $16.00 | $2,400,000.00 | 5% 3.04M to 3.19M | |
| 15-May-18 6:26 PM View: | Anaptysbio, Inc (ANAB) | 11-May-18 | Acquisition (other) | 301,024 | -- | -- | 11% 2.65M to 2.95M | |
| 15-May-18 6:26 PM View: | Anaptysbio, Inc (ANAB) | 11-May-18 | Acquisition (other) | 31,854 | -- | -- | 1% 2.95M to 2.98M | |
| 15-May-18 6:26 PM View: | Anaptysbio, Inc (ANAB) | 11-May-18 | Disposition (other) | 1,673,020 | -- | -- | (56%) 2.98M to 1.31M | |
| 06-Nov-17 7:06 PM View: | Allena Pharmaceuticals, Inc. (ALNA) | 06-Nov-17 | Conversion Duplicate | 2,830,370 | -- | -- | 100% 0 to 2.83M | |
| 06-Nov-17 7:06 PM View: | Allena Pharmaceuticals, Inc. (ALNA) | 06-Nov-17 | Purchase Duplicate | 500,000 | $14.00 | $7,000,000.00 | 18% 2.83M to 3.33M | |
| 26-Jul-17 5:11 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 24-Jul-17 | Grant | 2,199,010 | -- | -- | 100% 0 to 2.2M | |
| 16-Feb-17 5:11 PM View: | Sierra Oncology, Inc. (SRRA) | 14-Feb-17 | Market Purchase | 5,925,930 | $1.35 | $8,000,000.00 | 271% 2.19M to 8.11M | (69%) |
| 31-Jan-17 4:51 PM View: | Anaptysbio, Inc (ANAB) | 31-Jan-17 | Conversion | 3,171,210 | -- | -- | 100% 0 to 3.17M | |
| 31-Jan-17 4:51 PM View: | Anaptysbio, Inc (ANAB) | 31-Jan-17 | Private Purchase Duplicate | 400,000 | $15.00 | $6,000,000.00 | 13% 3.17M to 3.57M | |
| 21-Jul-15 7:04 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Conversion | 1,869,610 | -- | -- | 100% 0 to 1.87M | |
| 21-Jul-15 7:04 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Acquisition (other) | 96,589 | $5.22 | $503,712.00 | 5% 1.87M to 1.97M | |
| 21-Jul-15 7:04 PM View: | Sierra Oncology, Inc. (SRRA) | 21-Jul-15 | Purchase Duplicate | 220,000 | $17.00 | $3,740,000.00 | 11% 1.97M to 2.19M | |
| 30-May-13 4:52 PM View: | Portola Pharmaceuticals Inc (PTLA) | 28-May-13 | Conversion | 1,436,210 | -- | -- | 100% 0 to 1.44M | |
| 26-Feb-09 6:09 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 26-Feb-09 | Market Sale | 2,756,710 | $0.06 | $154,927.00 | (100%) 2.76M to 0 | (8058%) |
| 26-Feb-09 6:09 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 25-Feb-09 | Market Sale | 1,454,000 | $0.06 | $92,038.20 | (35%) 4.21M to 2.76M | (7143%) |
| 26-Feb-09 6:09 PM View: | La Jolla Pharmaceutical Co. (LJPC) | 24-Feb-09 | Market Sale Duplicate | 1,662,000 | $0.07 | $120,827.00 | (28%) 5.87M to 4.21M | (6206%) |
| 10-Mar-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 10-Mar-08 | Market Purchase Duplicate | 760 | $10.07 | $7,651.30 | < 1% 915.16K to 915.92K | 158% |
| 10-Mar-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 10-Mar-08 | Market Purchase Duplicate | 4,740 | $10.27 | $48,696.20 | < 1% 3.52M to 3.52M | 153% |
| 10-Mar-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 06-Mar-08 | Market Purchase Duplicate | 22,146 | $10.01 | $221,723.00 | 2% 893.02K to 915.16K | 159% |
| 05-Mar-08 9:29 PM View: | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-08 | Market Purchase Duplicate | 37,992 | $9.78 | $371,681.00 | 1% 3.46M to 3.49M | 166% |
| 05-Mar-08 9:28 PM View: | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-08 | Market Purchase Duplicate | 12,008 | $9.67 | $116,133.00 | 1% 843.02K to 855.03K | 169% |
| 05-Mar-08 9:28 PM View: | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-08 | Market Purchase Duplicate | 9,000 | $9.99 | $89,869.40 | 1% 834.02K to 843.02K | 160% |
| 05-Mar-08 9:27 PM View: | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-08 | Market Purchase Duplicate | 4,500 | $9.72 | $43,719.00 | < 1% 829.52K to 834.02K | 167% |
| 05-Mar-08 9:27 PM View: | Amicus Therapeutics, Inc. (FOLD) | 03-Mar-08 | Purchase | 18,426 | $1,341.62 | $24,720,600.00 | 2% 811.09K to 829.52K | (99%) |
| 05-Mar-08 9:25 PM View: | Amicus Therapeutics, Inc. (FOLD) | 03-Mar-08 | Market Purchase Duplicate | 43,674 | $9.67 | $422,230.00 | 6% 767.42K to 811.09K | 169% |
| 04-Mar-08 9:09 PM View: | Amicus Therapeutics, Inc. (FOLD) | 29-Feb-08 | Market Purchase | 8,637 | $9.88 | $85,355.90 | < 1% 3.36M to 3.37M | 163% |
| 28-Feb-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 28-Feb-08 | Market Purchase | 2,038 | $9.91 | $20,194.90 | < 1% 750.98K to 753.02K | 162% |
| 28-Feb-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 28-Feb-08 | Market Purchase | 5,762 | $10.08 | $58,068.40 | < 1% 3.35M to 3.36M | 158% |
| 28-Feb-08 9:39 PM View: | Amicus Therapeutics, Inc. (FOLD) | 27-Feb-08 | Market Purchase | 14,700 | $9.77 | $143,616.00 | 2% 727.68K to 742.38K | 166% |
| 28-Feb-08 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 27-Feb-08 | Market Purchase | 8,600 | $10.06 | $86,480.20 | 1% 742.38K to 750.98K | 158% |
| 28-Feb-08 9:39 PM View: | Amicus Therapeutics, Inc. (FOLD) | 26-Feb-08 | Market Purchase | 6,100 | $9.71 | $59,252.20 | < 1% 719.68K to 725.78K | 167% |
| 28-Feb-08 9:39 PM View: | Amicus Therapeutics, Inc. (FOLD) | 26-Feb-08 | Market Purchase | 1,900 | $10.17 | $19,322.90 | < 1% 725.78K to 727.68K | 155% |
| 25-Feb-08 9:01 PM View: | Amicus Therapeutics, Inc. (FOLD) | 25-Feb-08 | Market Purchase | 9,700 | $9.66 | $93,680.00 | 1% 709.98K to 719.68K | 169% |
| 25-Feb-08 9:00 PM View: | Amicus Therapeutics, Inc. (FOLD) | 22-Feb-08 | Market Purchase | 2,000 | $9.60 | $19,196.50 | < 1% 701.17K to 703.17K | 171% |
| 25-Feb-08 9:01 PM View: | Amicus Therapeutics, Inc. (FOLD) | 22-Feb-08 | Market Purchase | 6,614 | $9.86 | $65,218.40 | < 1% 703.17K to 709.78K | 163% |